Table 4.

Area Under the Time-Dependent Receiver Operating Characteristic Curve (AUC) to Quantify the Ability of Galectin-3, High-Sensitivity Soluble Toll-Like Receptor 2 (ST2), Troponin I, and B-Type Natriuretic Peptide (BNP) to Discriminate Major Adverse Events Through 1 and 5 Years of Follow-Up Among All Participants

	1 Year*		5 Years†
Marker	AUC (95% CI)	P Value‡	AUC (95% CI)	P Value‡
Galectin-3	0.627 (0.582–0.672)	—	0.644 (0.611–0.677)	—
High-sensitivity ST2	0.639 (0.588–0.690)	.70	0.627 (0.594–0.660)	.43
Troponin I	0.662 (0.626–0.698)	.19	0.682 (0.655–0.709)	.062
BNP	0.723 (0.683–0.763)	<.001	0.722 (0.691–0.753)	<.001

CI, confidence interval;.

^*Kaplan-Meier survival at 1 year: 0.889.

^†Kaplan-Meier survival at 5 years: 0.708.

^‡P values evaluate equality of each biomarker’s AUC with that of galectin-3.